Sarda Proteins Intrinsic Value

SRDAPRT • FMCG
Current Stock Price
₹71.22
Primary Intrinsic Value
₹14.24
Market Cap
₹21.4 Cr
-40.1% Downside
Median Value
₹42.67
Value Range
₹14 - ₹43
Assessment
Trading Above Calculated Value
Safety Margin
-66.9%

SRDAPRT Valuation Methods Summary

Method Type Intrinsic Value Range Upside/Downside Details
Book Value Method asset ₹14.24 ₹12.82 - ₹15.66 -80.0% Book Value/Share: ₹6.67, P/B: 1.0x
Revenue Multiple Method revenue ₹42.67 ₹38.40 - ₹46.94 -40.1% Revenue/Share: ₹53.33, P/S: 0.8x
Method Types: Earnings Asset DCF Growth Dividend Conservative

Want to compare with current market value? Check SRDAPRT share price latest .

Valuation Comparison Chart

SRDAPRT Intrinsic Value Analysis

What is the intrinsic value of SRDAPRT?

Based on our comprehensive analysis using 2 different valuation methods, the estimated intrinsic value of Sarda Proteins (SRDAPRT) is ₹42.67 (median value). With the current market price of ₹71.22, this represents a -40.1% variance from our estimated fair value.

The valuation range spans from ₹14.24 to ₹42.67, indicating ₹14.24 - ₹42.67.

Is SRDAPRT undervalued or overvalued?

Based on our multi-method analysis, Sarda Proteins (SRDAPRT) appears to be trading above calculated value by approximately 40.1%.

Financial Health Analysis

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Debt to Equity Ratio 1.50 Industry Standard: <0.5 Above 1.0 Indicates financial leverage level
Operating Margin -11.0% Industry Standard: 20%+ Below 10% Indicates operational efficiency level
Asset Turnover Ratio 5.33x Industry Standard: 1.0x+ Above 1.0x Measures asset utilization efficiency

Cash Flow Quality Analysis

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2024 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2023 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2022 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2021 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10